|
ZSCAN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.066200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.608100E-02 |
| Normal-vs-Stage2 |
3.229400E-01 |
| Normal-vs-Stage3 |
4.122000E-01 |
| Normal-vs-Stage4 |
6.972400E-01 |
| Stage1-vs-Stage2 |
6.694600E-01 |
| Stage1-vs-Stage3 |
2.306000E-01 |
| Stage1-vs-Stage4 |
2.334000E-02 |
| Stage2-vs-Stage3 |
6.736800E-01 |
| Stage2-vs-Stage4 |
2.244000E-01 |
| Stage3-vs-Stage4 |
2.960200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.868400E-02 |
| Normal-vs-AfricanAmerican |
3.025200E-01 |
| Normal-vs-Asian |
5.108100E-02 |
| Caucasian-vs-AfricanAmerican |
9.477200E-01 |
| Caucasian-vs-Asian |
4.613600E-01 |
| AfricanAmerican-vs-Asian |
6.829600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.468300E-02 |
| Normal-vs-Female |
2.016800E-01 |
| Male-vs-Female |
1.207170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.026200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.221900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.585400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.520600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.794800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.811600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.961800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.968400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.689600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.778400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.357500E-03 |
| Classical-VS-Follicular |
8.87469999710788E-08 |
| Classical-VS-Other |
9.568800E-01 |
| Classical-VS-Normal |
1.121170E-03 |
| Tall-VS-Follicular |
3.159600E-01 |
| Tall-VS-Other |
4.319200E-01 |
| Tall-VS-Normal |
4.690800E-01 |
| Follicular-VS-Other |
1.207610E-01 |
| Follicular-VS-Normal |
5.040100E-02 |
| Other-VS-Normal |
5.453400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.710580E-01 |
| Normal-vs-N1 |
9.298000E-01 |
| N0-vs-N1 |
2.834200E-01 |
|
|
